Skip to main content

Rozlytrek approved for ROS1-positive metastatic NSCLC, cancers with NTRK gene fusion defects

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Rozlytrek approved for ROS1-positive metastatic NSCLC, cancers with NTRK gene fusion defects

User login

Username

Password

Reset your password

Type	Lead	score